Pfizer’s Antiviral Pill for Covid Has Excellent Results
By Radiant Health EditorsPublished: December 19, 2021
New data recently released by Pfizer demonstrates that Paxlovid, the antiviral pill the company created to treat Covid patients, can reduce the risk of hospitalization or death by nearly 90% in high-risk adults. Pfizer also announced that preliminary results from a second study have shown that adult patients with a standard risk profile who take Paxlovid within a few days of showing symptoms of the virus have a 70% reduction of hospitalization and death.
Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.
- Coconut Cauliflower Rice With Jerk Chicken - November 29, 2024
- Protein Cottage Cheese Pancakes - November 27, 2024
- How To Reduce Screen Time On Phone: 5 Helpful Strategies To Help You Stay Connected With The Real World - October 30, 2024
- 11 Wellness Gift Ideas: Perfect Presents for Her that Nurture Body, Mind, and Soul - October 13, 2024
- 11 Best Indoor Air Purifying Plants: Nature’s Air Filters for Your Home - September 27, 2024
- 11 Best Health and Wellness Books to Read in 2025 - July 4, 2024
- Some Americans Will Have Medical Debt Wiped From Credit - July 9, 2022
- Natural Gas Used to Heat Homes Contains Some Harmful Chemicals - July 9, 2022
- Uterine Cancer Claims Many Black Lives - July 9, 2022
- Babies and Toddlers Get COVID-19 Shots - June 27, 2022